drugset / Trial / NCT03962920

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

NCT03962920

Recruiting 28 enrolled Zealand University Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a randomized controlled trial where patients undergoing surgical treatment for urogenital cancers will be randomized in a two arms study: surgical treatment + antibiotics OR surgical treatment + placebo.

Timeline

Start
2020-05-01
Primary completion
2025-05-01
Completion
2027-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tigecycline Small molecule 50 mg Other

Indications